SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
张三
Lv3
310 积分
2023-10-23 加入
最近求助
最近应助
互助留言
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
1天前
待确认
EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22
1天前
已完结
Clinical and biological activity of FLX475, an oral CCR4 antagonist, in advanced cancer
1天前
已完结
187P Phase I/II study of the oral CCR4 antagonist, FLX475, as monotherapy and in combination with pembrolizumab in advanced cancer
1天前
已完结
Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective
8天前
已完结
Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
8天前
已完结
Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy
18天前
已完结
Tumor Microenvironment Regulates Immune Checkpoints: Emerging Need of Combinatorial Therapies
20天前
已完结
Gemox chemotherapy in combination with anti-PD1 antibody toripalimab and lenvatinib as first-line treatment for advanced intrahepatic cholangiocarcinoma: A phase 2 clinical trial
21天前
已完结
Safety and clinical activity of target-preserving anti-CTLA-4 antibody ONC-392 as monotherapy in NSCLC patients who progressed on PD(L)1-targeted immunotherapy
22天前
已完结
没有进行任何应助
已找到【积分已退回】
10个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论